Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-27T01:58:10.048Z Has data issue: false hasContentIssue false
  • English
  • Français

Degradation of Poly(Anhydride-Co-Imides): Novel Polymers for Orthopedic Applications

Published online by Cambridge University Press:  21 February 2011

Kathryn E. Uhrich ,
Sobrasua E. M. Ibim ,
Cato T. Laurencin  and
Robert Langer
Kathryn E. Uhrich
Affiliation:
Massachusetts Institute of Technology, Department of Chemical Engineering, Cambridge, MA 02139
Sobrasua E. M. Ibim
Affiliation:
Massachusetts Institute of Technology, Department of Chemical Engineering, Cambridge, MA 02139
Cato T. Laurencin
Affiliation:
Medical College of Pennsylvania, Department of Orthopedics, Philadelphia, PA 19129
Robert Langer
Affiliation:
Massachusetts Institute of Technology, Department of Chemical Engineering, Cambridge, MA 02139
Get access

Abstract

Novel polymers with good mechanical properties are being developed as degradable matrices for bone growth and regeneration. The poly(anhydride-co-imides) were synthesized from trimellitylimidoglycine and 1,6-bis(p-carboxyphenoxy)hexane in molar compositions of 10:90, 30:70 and 50:50. These polymers have compressive strengths (23–57 MPa), which are similar to human cortical bone. 1 In vitro degradation was performed under acidic (pH 5), physiological (pH 7.4), and basic (pH 10) conditions. The degradation rate increased under basic conditions and by increasing the amount of trimellitylimidoglycine in the polymer backbone. Two erosion zones were observed in the polymers by microscopy. In vivo polymer degradation was evaluated by characterizing polymer discs implanted in subcutaneous tissue of rats over a 56 day time period. Copolymers with the highest ratio of trimellitylimidoglycine in the polymer backbone were completely degraded by 56 days, the other compositions remained in the tissue as solid pellets at this time. In vivo degradation was much slower than the corresponding in vitro degradation.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 394: Symposium Z – Polymers in Medicine and Pharmacy , 1995 , 41
Copyright
Copyright © Materials Research Society 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Uhrich, K. E., Gupta, A., Thomas, T.T., Gupta, A., Laurencin, C.T. and Langer, R., Macromolecules 28, 2184 (1995).Google Scholar
2. Chasin, M., Domb, A., Ron, E., Mathiowitz, E., Leong, K., Laurencin, C., Brem, H., Grossman, S. and Langer, R., in Biodegradable Polymers as Drug Delivery Systems, edited by Chasin, M. and Langer, R. (Marcel Dekker, New York, NY, 1990), pp. 43–70.Google Scholar
3. Staubli, A., Ron, E. and Langer, R., J. Am. Chem. Soc. 112, 4419 (1990).Google Scholar
4. Baker, R.W., Controlled Release of Biologically Active Agents (Wiley, New York, 1987), p. 84.Google Scholar
5. Joshi, A. and Himmelstein, K.J., J. Contr. Rel. 15, 95 (1991).Google Scholar
6. Li, S.M., Garreau, H., Vert, M., J. Mat. Sci. Mat. Med. 1, 131 (1990).Google Scholar
7. Leong, K.W., Brott, B.C., and Langer, R., J. Biomed. Mater. Res. 19, 941 (1985).Google Scholar
8. Laurencin, C.T., PhD thesis, Massachusetts Institute of Technology, 1987.Google Scholar
9. Seidel, J., MS thesis, ETH Zürich, Switzerland, 1995.Google Scholar